XBiotech Inc. (XBIT) stock
XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.00 (0.00%)
Close on Nov 13, 2026Market cap $59.76MP/E –Yield –
XBiotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
XBiotech's price to sales ratio was 465.7× on Jan 31, 2024, against 16.1× a year earlier. Over the last 4 years it ranged from 9.7× to 465.7×, with a median of 17.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Jan 31, 2024 | 465.7× | +59.9 |
| 2023 | Dec 29, 2023 | 405.8× | +392.8 |
| 2022 | Dec 30, 2022 | 13.0× | −4.6 |
| 2021 | Dec 31, 2021 | 17.7× | +5.8 |
| 2020 | Dec 31, 2020 | 11.8× | – |
See a number that looks wrong?